Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110452150A reveals mild chiral phosphoric acid catalysis. Enables cost reduction in fine chemical intermediates manufacturing with high enantioselectivity.
Discover a novel method for preparing chiral spiro indolone compounds using cinchona alkaloid catalysts. High yield, mild conditions, and scalable pharma intermediate production.
Patent CN103665036B details novel chiral ligands enabling high-purity pharmaceutical intermediate manufacturing with significant cost reduction and supply chain reliability.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles with high enantioselectivity for anticancer drug development and pharmaceutical intermediates.
Patent CN107698590B details a novel asymmetric [3+2] cyclization for chiral carbocyclic purine nucleosides, offering high yields and enantioselectivity for reliable pharmaceutical intermediate supply.
Patent CN110467555B reveals a novel chiral phosphoric acid catalyzed method for synthesizing axially chiral indoles with high enantioselectivity, offering significant cost reduction in API manufacturing.
Patent CN114920775B introduces a novel axial chiral bisindole catalyst offering high enantioselectivity and mild conditions for scalable pharmaceutical intermediate manufacturing.
Patent CN111777637B discloses a novel oxindole-derived phosphine catalyst enabling mild asymmetric cyclizations with excellent yields and supply chain stability.
Advanced synthesis of spiro quaternary ammonium salts via kinetic resolution. Offers superior enantioselectivity for amino acid synthesis with scalable industrial processes.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN114057717B reveals novel ligand synthesis enhancing enantioselectivity. Delivers substantial cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel synthesis method patent CN116199614B offers high enantioselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN111848322B details a novel chiral phosphoric acid resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones with potent anti-tumor activity, offering reliable supply chain solutions.
Patent CN110467555B reveals a chiral phosphoric acid catalyzed route for high-purity axial chiral aryl indoles, offering cost-effective API intermediate manufacturing.
Patent CN113461589B details a novel one-step asymmetric Friedel-Crafts reaction for chiral 2,3-disubstituted indoleamines, offering significant cost reduction in API manufacturing.
Novel chiral phosphoric acid catalyzed synthesis of indoxazinones with high enantioselectivity and mild conditions for anticancer drug development.
Patent CN114160206B reveals a novel chiral copper catalyst for optically active indoles. Achieve >91% ee and substantial cost reduction in API manufacturing with scalable processes.
Patent CN114920775B reveals high-selectivity catalyst synthesis. Offers cost reduction in pharmaceutical manufacturing and reliable supply chain solutions.